Piper Jaffray Starts Inovio Pharmaceuticals (INO) at Overweight
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.09 +21.11%
Rating Summary:
11 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Jaffray initiates coverage on Inovio Pharmaceuticals (NYSE: INO) with a Overweight. PT $1.00.
For an analyst ratings summary and ratings history on Inovio Pharmaceuticals click here. For more ratings news on Inovio Pharmaceuticals click here.
Shares of Inovio Pharmaceuticals closed at $0.67 yesterday.
For an analyst ratings summary and ratings history on Inovio Pharmaceuticals click here. For more ratings news on Inovio Pharmaceuticals click here.
Shares of Inovio Pharmaceuticals closed at $0.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Neutral Rating on Inovio Pharmaceuticals (INO)
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
- UBS Starts Schrodinger (SDGR) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
